Clinical Trial Update: Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of Interferon alfa in patients with stage IV solid tumors, lymphoma, or multiple myeloma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Kidney Cancer
• Lymphoma
• Melanoma
• Multiple Myeloma
• Sarcoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Breast Cancer, Kidney Cancer | Phase 1 | Status: COMPLETED